PE eyes growth opportunities in active pharmaceutical ingredients: 5 deals
Astorg, EQT, New Mountain Capital and TA Associates are among the PE firms buying and selling active pharmaceutical ingredient assets.
6 March 2026•4 mins read
Astorg, EQT, New Mountain Capital and TA Associates are among the PE firms buying and selling active pharmaceutical ingredient assets.